HomeCompareORRRY vs PLD

ORRRY vs PLD: Dividend Comparison 2026

ORRRY yields 1.92% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.48M in total portfolio value
10 years
ORRRY
ORRRY
● Live price
1.92%
Share price
$0.30
Annual div
$0.01
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$0.19
Full ORRRY calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — ORRRY vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORRRYPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORRRY + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ORRRY pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORRRY
Annual income on $10K today (after 15% tax)
$162.92/yr
After 10yr DRIP, annual income (after tax)
$0.16/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,467,970.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORRRY + PLD for your $10,000?

ORRRY: 50%PLD: 50%
100% PLD50/50100% ORRRY
Portfolio after 10yr
$3.26M
Annual income
$2,628,218.19/yr
Blended yield
80.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ORRRY
No analyst data
Altman Z
0.2
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORRRY buys
0
PLD buys
0
No recent congressional trades found for ORRRY or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORRRYPLD
Forward yield1.92%3.18%
Annual dividend / share$0.01$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%74.4%
Portfolio after 10y$20.0K$6.50M
Annual income after 10y$0.19$5,256,436.18
Total dividends collected$193.00$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ORRRY vs PLD ($10,000, DRIP)

YearORRRY PortfolioORRRY Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,796$95.83$11,255$555.24$459.00PLD
2$11,600$48.35$13,062$1,018.59$1.5KPLD
3$12,436$24.27$15,903$1,926.67$3.5KPLD
4$13,319$12.16$20,839$3,823.32$7.5KPLD
5$14,257$6.09$30,464$8,166.08$16.2KPLD
6$15,258$3.04$52,054$19,457.30$36.8KPLD
7$16,328$1.52$109,886$54,188.93$93.6KPLD
8$17,472$0.76$304,030$186,451.18$286.6KPLD
9$18,695$0.38$1,166,125$840,813.32$1.15MPLD
10$20,004$0.19$6,504,190$5,256,436.18$6.48MPLD

ORRRY vs PLD: Complete Analysis 2026

ORRRYStock

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.

Full ORRRY Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ORRRY vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORRRY vs SCHDORRRY vs JEPIORRRY vs OORRRY vs KOORRRY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.